India will begin trials of two new drugs to treat Covid-19 as part of the WHO Solidarity Clinical Trials.

The WHO Solidarity PLUS experiment includes 52 nations, with India being one of them. The efficacy of another medicine, artesunate, which is used to treat severe malaria, is also being investigated by the Covid-19 research collaboration. This third medicine will be tested in several other nations.

This month, India will launch Solidarity PLUS, the next phase of the World Health Organization’s Solidarity trial, which will assess the efficacy of new medications in treating hospitalised patients with Covid-19.

Imatinib and Infliximab, two medications already in use for different illnesses, will be studied in the Indian trial. Imatinib is a drug that is used to treat cancer.

“The trials would most likely start as soon as we receive the medications,” a senior official said, adding that it probably be this month.

Medically Speaking Team

Recent Posts

Dysautonomia: The Silent Illness Affecting Millions Globally

Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…

2 days ago

Chyawanprash: Your Ayurvedic Shield Against Cough & Cold

https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…

2 days ago

Why Winter Morning Walks (7-9 AM) Are Perfect for Your Health

Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…

2 days ago

Does Maida Stick to Your Gut? Debunking Myths and Health Risks

Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…

2 days ago

Think Twice Before Heating Packaged Milk: Hidden Risks You Should Know!

https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…

2 days ago

MENTAL HEALTH STRUGGLES: THE LONG-TERN IMPACT ON TEENAGERS

A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…

3 days ago